LARGACTIL

This brand name is authorized in Australia, Estonia, France, Lithuania, Malta, New Zealand, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug LARGACTIL contains one active pharmaceutical ingredient (API):

1	Chlorpromazine UNII 9WP59609J6 - CHLORPROMAZINE HYDROCHLORIDE
	Chlorpromazine is a phenothiazine neuroleptic. Chlorpromazine has depressant actions on the Central Nervous System, with alpha-adrenergic blocking and anticholinergic activities. It has anti-emetic, anti-puritic, serotonin-blocking and weak anti-histamine properties and slight ganglion blocking activity.
	Read more about Chlorpromazine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
LARGACTIL Solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N05AA01	Chlorpromazine	N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AA Phenothiazines with aliphatic side-chain
Discover more medicines within N05AA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	1195X, 1196Y, 1197B, 1199D, 1201F, 3455W
EE	Ravimiamet	1782435, 1875797, 1875809, 1875843, 1875854
ES	Centro de información online de medicamentos de la AEMPS	19622, 23661, 23665, 42934
FR	Base de données publique des médicaments	62184888, 62816804, 65676987, 68513504
GB	Medicines & Healthcare Products Regulatory Agency	27333
LT	Valstybinė vaistų kontrolės tarnyba	1090511
MT	Medicines Authority	AA565/12402, AA565/12403, AA565/12404
NZ	Medicines and Medical Devices Safety Authority	368, 369, 372, 373
TN	Direction de la Pharmacie et du Médicament	6390051, 6390052, 6390053
TR	İlaç ve Tıbbi Cihaz Kurumu	8699586090271, 8699586750137